Schedule Medical Evaluation
Seek care for a node that lasts several weeks, enlarges, feels hard or fixed, or appears without a clear infection.
- Track node size and duration
- Bring prior imaging
Lymphoma treatment is led by hematology-oncology. GastroDoxs supports patients when lymphoma affects the digestive system or when endoscopy, biopsy, bleeding evaluation, nutrition, or treatment-side-effect care is needed.
Lymphoma treatment depends on the exact Hodgkin or non-Hodgkin subtype, stage, growth rate, biomarkers, symptoms, and overall health. GastroDoxs GutRescue Mission™ supports the GI portion of care by connecting digestive symptoms, imaging, endoscopic tissue needs, bleeding, nutrition, liver involvement, and oncology treatment effects with the appropriate specialist pathway.
Treatment-stage care connects the diagnosis with practical options, safety review, monitoring, and specialist coordination.
We evaluate abdominal pain, bleeding, bowel changes, swallowing symptoms, nausea, liver-test abnormalities, and nutrition problems during lymphoma care.
We coordinate upper endoscopy, colonoscopy, EUS, or targeted tissue sampling when a digestive lesion may represent lymphoma.
We help manage nausea, diarrhea, constipation, mucosal injury, bleeding, liver effects, and nutritional decline related to cancer treatment.
We direct systemic lymphoma treatment decisions to the appropriate oncology team and share GI findings that affect care.
A clear path from scheduling and records review to a personalized treatment plan.
Share your current lymphoma symptoms, diagnosis, treatment history, goals, and the questions you need answered.
Bring pathology reports, PET or CT imaging, oncology treatment plan, blood tests, medication list, endoscopy reports, symptom timeline, nutrition and weight changes, and details about bleeding or severe abdominal symptoms.
A GastroDoxs GI specialist reviews the diagnosis, treatment options, safety factors, expected benefits, and whether another specialist or procedure is needed.
Your lymphoma plan may include medication, nutrition, lifestyle care, testing, a procedure, monitoring, or coordinated referral.
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
Your rescue plan. When your diagnosis is confirmed, GastroDoxs GutRescue Mission™ deploys at full force - a gastroenterologist-led intervention plan delivering advanced colonoscopy, upper endoscopy, capsule endoscopy, and precision biologic and medication management across the full range of digestive conditions and complex GI emergencies - fighting for you with everything we have.
Schedule non-emergency care when you need treatment selection, reassessment, monitoring, or specialist coordination.
Seek care for a node that lasts several weeks, enlarges, feels hard or fixed, or appears without a clear infection.
The biopsy is reviewed for morphology, immunophenotype, genetics, and molecular features.
Schedule GI review for persistent diarrhea, constipation, nausea, swallowing difficulty, abdominal pain, bleeding, jaundice, or unexplained weight loss during treatment.
Endoscopy, nutrition support, surgery, or urgent treatment may be needed for bleeding, obstruction, perforation risk, or severe malabsorption.
Lymphoma treatment is subtype-specific and oncology-led. GastroDoxs provides GI evaluation, endoscopic support, symptom management, and coordination when the digestive system is involved.
GastroDoxs provides patient-facing treatment planning for lymphoma, including records review, medication and procedure questions, symptom monitoring, insurance guidance, and coordinated referral when another specialist is needed.
Lymphoma treatment depends on the exact subtype and stage. Options may include observation, chemotherapy, targeted therapy, immunotherapy, radiation, stem-cell transplant, cellular therapy, or combinations planned by a lymphoma-focused hematology-oncology team.
Hodgkin lymphoma is commonly treated with combination chemotherapy, sometimes with radiation, targeted therapy, or immunotherapy. The regimen depends on stage, risk features, response imaging, age, fertility goals, and overall health.
Non-Hodgkin lymphoma treatment varies widely by subtype. Indolent disease may be observed or treated with antibody-based therapy, while aggressive disease may require combination chemoimmunotherapy, targeted agents, cellular therapy, or transplant.
Doctors consider pathology subtype, stage, growth rate, molecular features, symptoms, organ involvement, prior treatment, age, pregnancy or fertility plans, heart and lung health, and patient preferences.
Many lymphomas are curable, especially several Hodgkin and aggressive non-Hodgkin subtypes. Others are treated as chronic diseases with long remissions. Prognosis depends on subtype, stage, biology, and treatment response.
Chemotherapy kills rapidly dividing lymphoma cells and may be combined with antibodies, targeted drugs, radiation, or transplant. The specific regimen and number of cycles depend on subtype and stage.
Yes. Targeted medicines act on specific proteins or pathways in lymphoma cells and are used in many B-cell and T-cell lymphomas, either initially or after recurrence.
Immunotherapy helps the immune system recognize or attack lymphoma. Options include monoclonal antibodies, checkpoint inhibitors, bispecific antibodies, and CAR T-cell therapy for selected subtypes.
Radiation may be used for localized disease, bulky areas, residual sites, symptom relief, or selected Hodgkin and non-Hodgkin lymphomas. It is planned to limit exposure to nearby healthy tissue.
Treatment may last several weeks to many months. Duration depends on subtype, stage, number of cycles, response, complications, and whether transplant or cellular therapy is needed.
Possible effects include fatigue, nausea, infection risk, low blood counts, hair loss, neuropathy, bowel changes, mouth sores, fertility effects, organ toxicity, and late effects. The exact profile depends on the regimen.
A stem-cell transplant may be considered for selected relapsed, refractory, or high-risk lymphomas after response to intensive treatment. Eligibility depends on subtype, disease status, age, organ function, and overall fitness.
Doctors use symptom review, physical examination, blood tests, PET-CT or CT, and sometimes bone marrow or tissue evaluation. Response criteria depend on the lymphoma subtype and treatment.
Balanced nutrition, physical activity as tolerated, sleep, infection precautions, smoking cessation, emotional support, and prompt reporting of side effects can support recovery. Lifestyle measures do not replace oncology treatment.
Expect pretreatment testing, scheduled therapy cycles or observation, blood and imaging monitoring, side-effect management, and a survivorship or maintenance plan. GastroDoxs supports digestive symptoms, endoscopic needs, and nutrition in coordination with oncology.
Book GastroDoxs for lymphoma-related digestive symptoms, endoscopic biopsy coordination, bleeding or liver concerns, nutrition support, or GI treatment-side-effect management.